Trial Profile
Multicenter Registry of High-Risk Percutaneous Coronary Intervention and Adequate Platelet Inhibition
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 24 Apr 2007
Price :
$35
*
At a glance
- Drugs Eptifibatide (Primary) ; Tirofiban (Primary) ; Clopidogrel
- Indications Coronary artery disease; Embolism and thrombosis
- Focus Pharmacodynamics
- Acronyms MR-PCI
- 24 Apr 2007 New trial record.